A pharmaceutical composition for the prevention and treatment of non-alcoholic steatohepatitis, liver fibrosis and cirrhosis containing an adenosine derivative.

摘要

PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for preventing or treating liver disease. SOLUTION: A compound having the following structural formula or a pharmaceutically acceptable salt thereof is contained as an active ingredient, and at least one liver disease selected from the group consisting of non-alcoholic steatohepatitis, liver fibrosis and cirrhosis. A prophylactic or therapeutic pharmaceutical composition.[A is S; R is halogen-substituted benzyl; Y is H or halogen element] [Selection diagram] FIG. 7